ArticleFrontiers in oncology2022

Epigenetics-Associated Risk Reduction of Hematologic Neoplasms in a Nationwide Cohort Study: The Chemopreventive and Therapeutic Efficacy of Hydralazine.

Bing-Heng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.